WEBULL
News
CLVSF
23.33
NaN%
--
CellaVision’s Bone Marrow Application Achieves CE Marking
TipRanks · 12/08/2025 06:34
CellaVision AB Reports Mixed Q3 2025 Performance
TipRanks · 11/07/2025 04:05
CellaVision AB’s Earnings Call: Strategic Gains Amid Challenges
TipRanks · 11/07/2025 00:02
CellaVision Reports Mixed Q3 Performance Amid Strategic Advancements
TipRanks · 11/06/2025 06:35
CellaVision to Present Q3 2025 Report on November 6
TipRanks · 10/23/2025 06:34
CellaVision Announces Nomination Committee for 2026 AGM
TipRanks · 10/21/2025 06:34
Weekly Report: what happened at CLVSF last week (0908-0912)?
Weekly Report · 09/15/2025 11:29
Weekly Report: what happened at CLVSF last week (0901-0905)?
Weekly Report · 09/08/2025 11:32
CellaVision Appoints Monica Jönsson as Interim CFO
TipRanks · 09/02/2025 08:33
Weekly Report: what happened at CLVSF last week (0825-0829)?
Weekly Report · 09/01/2025 11:26
Weekly Report: what happened at CLVSF last week (0818-0822)?
Weekly Report · 08/25/2025 11:38
Qiagen: Diagnostics Vs. Life Sciences Pair Trade Analysis
Seeking Alpha · 08/21/2025 13:52
Weekly Report: what happened at CLVSF last week (0811-0815)?
Weekly Report · 08/18/2025 11:29
Weekly Report: what happened at CLVSF last week (0804-0808)?
Weekly Report · 08/11/2025 11:38
Weekly Report: what happened at CLVSF last week (0728-0801)?
Weekly Report · 08/04/2025 11:40
Weekly Report: what happened at CLVSF last week (0721-0725)?
Weekly Report · 07/28/2025 11:41
Weekly Report: what happened at CLVSF last week (0714-0718)?
Weekly Report · 07/21/2025 11:30
CellaVision AB Reports Steady Q2 2025 Performance
TipRanks · 07/19/2025 03:57
CellaVision Reports Robust Q2 2025 Performance Amid Regional Variations
TipRanks · 07/18/2025 05:33
Weekly Report: what happened at CLVSF last week (0707-0711)?
Weekly Report · 07/14/2025 11:40
More
Webull provides a variety of real-time CLVSF stock news. You can receive the latest news about Cellavision through multiple platforms. This information may help you make smarter investment decisions.
About CLVSF
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.